Dr. Jayadeepa Srinivas Raju

Dr. Jayadeepa Srinivas Raju is a leading Onco-radiologist based out of Bangalore, India. An illustrious alumnus of M.S.Ramaiah Medical College and Narayana Hrudayalaya, she has over 12 years experience with expert reviewership and adjudication of multiple national and international clinical trials, focused on Onco-radiology. She has presented in several conferences and published on the radiological imaging features associated with newer onco-therapeutic modalities. She has a keen interest in Artificial Intelligence, having partnered with various global companies on data analytics, development, validation, deployment and testing of radiology AI algorithms.

Dr. Jayadeepa Srinivas Raju

Dr. Jayadeepa Srinivas Raju has been actively collaborating with Dr. Gesundheit and their team of oncologists in providing observational and investigative radiological assessments and discussing the various manifestations of treatment-related outcomes, focused around oncolytic virotherapy. Her radiological assessments encompass immune-mediated and other novel therapeutic options with timeline reviews, comparative analytics, tumor metrics and volume rendered 3D imaging on an explorative and experimental basis to assist treating physicians with the best therapeutic approach and clinical rationale, and supported with latest literature review. 

Dr. Jayadeepa Srinivas Raju Professional Details

Professional credentials:
Registration: Karnataka Medical Council 71765
MBBS: M S Ramaiah Medical College 2004
DNB: Masters in Radiodiagnosis 2009
Chief Scientific Officer and expert adjudicator –  Image Core Lab, Bangalore till 2018
Head of Clinical Sciences – 5C Network Pvt Ltd, Bangalore, India – till 2022 
Clinical AI Subject Matter Expert – Healthminds, Bangalore, India – till present
Chief Oncoradiologist – AT Gesundheit Institute – 2018 till present 

Further Reading:

Combination of Loco-Regional Chemotherapy and Oncolytic Virotherapy to Treat a Metastatic GastroEsophageal Tumor

Authors: Benjamin Gesundheit , Jayadeepa Srinivas Raju, Yehudit Posen, Ronald Ellis, Karl Aigner and Arno Thaller

Publication: Oncology Case Reports Journal, December 4, 2020


About us

The ATGesundheit Institute website presents information about oncolytic virus (OV) cancer immunotherapy for glioblastoma multiforme (GBM), solid tumors and breast cancer. Our website is dedicated to exploring the therapeutic potential of OVs for incurable tumors and the therapeutic mechanisms of various OVs.

Contact US

Scroll to Top
Skip to content